Publicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (18)

2022

  1. Executive summary clinical practice guideline of postmenopausal, glucocorticoid-induced, and male osteoporosis (2022 update)

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 14, Núm. 1, pp. 5-12

2020

  1. Correction to: Panel Discussion: Some Aspects of the Management of Patients with X-Linked Hypophosphataemic Rickets (Advances in Therapy, (2020), 37, S2, (121-126), 10.1007/s12325-019-01208-w)

    Advances in Therapy

  2. Correction to: Panel Discussion: Some Aspects of the Management of Patients with X-Linked Hypophosphataemic Rickets (Advances in Therapy, (2020), 37, S2, (121-126), 10.1007/s12325-019-01208-w)

    Advances in Therapy

  3. Panel Discussion: Some Aspects of the Management of Patients with X-Linked Hypophosphataemic Rickets

    Advances in Therapy, Vol. 37, pp. 121-126

2019

  1. Osteoporosis and Psoriasis

    Actas Dermo-Sifiliograficas

  2. The next step after anti-osteoporotic drug discontinuation: an up-to-date review of sequential treatment

    Endocrine, Vol. 64, Núm. 3, pp. 441-455

2018

  1. Consensus document on osteoporosis in males

    Endocrinologia, Diabetes y Nutricion, Vol. 65, pp. 9-16

2016

  1. Validation of PHPQoL, a disease-specific quality-of-life questionnaire for patients with primary hyperparathyroidism

    Journal of Clinical Endocrinology and Metabolism, Vol. 101, Núm. 4, pp. 1571-1578

2012

  1. Fe de errores de "Guías de práctica clínica para la evaluación y tratamiento de la osteoporosis asociada a enfermedades endocrinas y nutricionales"

    Endocrinologia y Nutricion

  2. Results from a national survey on the management of primary hyperparathyroidism

    Journal of Endocrinological Investigation, Vol. 35, Núm. 11, pp. 957-963

2009

  1. Addendum

    Endocrinologia y Nutricion, Vol. 56, Núm. SUPPL. 1, pp. 48-49

  2. Editorial

    Endocrinologia y Nutricion

2007

  1. Osteoporosis: Report of the Working Group for Bone and Mineral Metabolism of the Spanish Society of Endocrinology and Nutrition

    Endocrinologia y Nutricion, Vol. 54, Núm. 1, pp. 53-61

2004

  1. Eficacia del tratamiento con alendronato en una población Española de mujeres posmenopáusicas con masa ósea baja. Resultados en España del ensayo multinacional fosit

    Revista Espanola de Enfermedades Metabolicas Oseas, Vol. 13, Núm. 6, pp. 122-128

1997

  1. Antiresorptive Therapy in Hyperthyroid Patients: Longitudinal Changes in Bone and Mineral Metabolism

    Journal of Clinical Endocrinology and Metabolism, Vol. 82, Núm. 6, pp. 1989-1994

  2. Bone loss in hyperthyroid patients and in former hyperthyroid patients controlled on medical therapy: Influence of aetiology and menopause

    Clinical Endocrinology, Vol. 47, Núm. 3, pp. 279-285

  3. Identification of metabolic bone disease in patients with endogenous hyperthyroidism: Role of biological markers of bone turnover

    Calcified Tissue International, Vol. 61, Núm. 5, pp. 370-376

1996

  1. Bone mineral density measured by dual X-ray absorptiometry in Spanish patients with insulin-dependent diabetes mellitus

    Calcified Tissue International, Vol. 58, Núm. 5, pp. 316-319